Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Queensland Health
Citi
Merck
Chubb
Cantor Fitzgerald
Moodys
Chinese Patent Office
AstraZeneca

Generated: May 23, 2018

DrugPatentWatch Database Preview

POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9% Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Potassium Chloride 0.224% In Sodium Chloride 0.9%, and what generic alternatives are available?

Potassium Chloride 0.224% In Sodium Chloride 0.9% is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9% is potassium chloride; sodium chloride. There are two hundred and thirty-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.
Summary for POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%
Drug patent expirations by year for POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%
Pharmacology for POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%

US Patents and Regulatory Information for POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare POTASSIUM CHLORIDE 0.224% IN SODIUM CHLORIDE 0.9% potassium chloride; sodium chloride INJECTABLE;INJECTION 017648-003 Approved Prior to Jan 1, 1982 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Argus Health
Covington
Federal Trade Commission
Fuji
Express Scripts
McKinsey
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.